Stealthy artificial intelligence-based medical imaging diagnostic group Imagen Technologies raised $14.3 million in a new round of equity financing, according to an SEC filing posted this week.
The New York-based company is developing AI-based software designed to reduce diagnostic errors by detecting clinically-meaningful pathologies within the images it scans, according to the company’s LinkedIn page.
Imagen has not yet released any details of its software or other products in development.
Money in the funding round came from 28 unnamed investors, according to the SEC filing, with the 1st sale logged on March 3, 2017.
The company is looking for an additional $679,001 before closing the round.